Not sure anyone said a lot, just that it was positive growth in...

Not sure anyone said a lot, just that it was positive growth in revenue.

Do you have any evidence that less than half are still on their prescription?

True while they are selling another company's product rebadged, they will soon be producing their own product in Australia available for export. I'm not an expert here but I don't think that getting the cultivation license, lease and building permits for cultivating your own cannabis crops is something another company could do in weeks/months. This should no doubt lead to increased margins on those products.

Furthermore, the significant advantage that AGH has over other potential competing companies is the ability to penetrate markets with tight legislation around prescription using concierge and medic platforms.